Cell and Bioscience
Scope & Guideline
Elevating the Standards of Cellular and Bioscience Inquiry
Introduction
Aims and Scopes
- Cellular Mechanisms and Signaling Pathways:
Research articles often explore intricate signaling pathways and cellular mechanisms, including the role of various proteins, RNA modifications, and metabolic processes in health and disease. - Stem Cell Biology and Regenerative Medicine:
The journal frequently publishes studies on stem cell biology, differentiation, and their therapeutic applications in regenerative medicine and tissue engineering. - Cancer Biology and Therapeutics:
A significant portion of the research focuses on cancer biology, examining tumor biology, metastasis, and exploring novel therapeutic strategies and biomarkers. - Neuroscience and Neurodegenerative Diseases:
The journal addresses various aspects of neuroscience, including neural development, neuroinflammation, and neurodegenerative diseases, contributing to a better understanding of brain-related disorders. - Microbiology and Infectious Diseases:
Research on host-pathogen interactions, immune responses, and the development of therapeutic interventions against infectious diseases is a prominent theme. - Metabolism and Disease:
Studies related to metabolic disorders, their cellular mechanisms, and potential therapeutic interventions are also key areas of focus.
Trending and Emerging
- RNA Modifications and Epitranscriptomics:
There is a growing emphasis on the role of RNA modifications, particularly m6A and other epitranscriptomic changes, in regulating gene expression and their implications in various diseases, including cancer and neurodegenerative disorders. - Microbiome and Host Interactions:
Research exploring the interplay between the microbiome and host health is on the rise, particularly its influence on metabolic diseases, immune responses, and cancer progression. - Organoid Models for Disease Modeling:
The use of organoid technology is increasingly prominent, providing innovative platforms for studying disease mechanisms and testing therapeutic interventions in a more physiologically relevant context. - Immunotherapy and Cancer Immunology:
Publications focusing on the mechanisms of immunotherapy, including the role of immune checkpoints and the tumor microenvironment, are trending as researchers seek to enhance treatment efficacy. - Metabolic Reprogramming in Cancer:
Emerging studies are increasingly focusing on the metabolic pathways in cancer cells, exploring how metabolic reprogramming contributes to tumorigenesis and resistance to therapies. - Gene Editing Technologies and Applications:
The application of CRISPR/Cas9 and other gene editing technologies is gaining traction, with research exploring their potential in therapeutic contexts and the ethical implications surrounding their use.
Declining or Waning
- Basic Mechanisms of Epithelial-Mesenchymal Transition (EMT):
Although EMT has been a significant area of study in cancer biology, the frequency of publications focusing solely on the mechanistic aspects of EMT appears to be decreasing, possibly due to a shift towards more integrative approaches that encompass broader cellular interactions. - Traditional Pharmacological Approaches:
There is a noticeable reduction in studies highlighting traditional pharmacological interventions, as the journal's focus is increasingly leaning towards innovative therapies, including gene editing and personalized medicine. - In Vitro Models of Disease:
The use of conventional in vitro models is becoming less prominent, as researchers are moving towards more complex and physiologically relevant models such as organoids and 3D cultures. - Single-Cell Analysis Techniques:
While single-cell technologies have gained significant attention, the specific focus on traditional single-cell sequencing methods is waning, with a greater emphasis now on integrating these techniques with spatial transcriptomics.
Similar Journals
CELLULAR AND MOLECULAR LIFE SCIENCES
Fostering Breakthroughs in Cellular and Molecular ResearchCELLULAR AND MOLECULAR LIFE SCIENCES, published by SPRINGER BASEL AG, stands as a premier journal dedicated to advancing the field of cellular and molecular biology. With an impressive 2023 impact factor reflected in its Q1 rankings across key categories—including Cell Biology, Molecular Biology, and Pharmacology—it serves as a critical platform for researchers aiming to disseminate high-quality findings in these dynamic fields. Operated under an open access framework, the journal allows broader accessibility to groundbreaking research, fostering collaboration amongst scientists globally. Based in Switzerland, CELLULAR AND MOLECULAR LIFE SCIENCES has been at the forefront of scientific publishing since 1952, adapting to contemporary scientific challenges and trends, ultimately shaping the future of life sciences.
JOURNAL OF CELLULAR PHYSIOLOGY
Pioneering Insights into Cellular DynamicsJOURNAL OF CELLULAR PHYSIOLOGY, published by Wiley, is a leading peer-reviewed journal that has been at the forefront of cellular research since its inception in 1945. With its prestigious Q1 and Q2 rankings in the fields of Clinical Biochemistry and Cell Biology, this journal is highly regarded within the scientific community, reflecting its significant impact factor and rigorous peer-review process. Addressing the intricacies of cell function and physiology, it serves as a crucial resource for researchers, professionals, and students dedicated to advancing knowledge in the life sciences. The journal publishes cutting-edge research articles, integral reviews, and significant findings that bridge basic biology and clinical applications, ensuring access to high-quality scholarly content that informs current practices and future research directions. Although not open access, the journal maintains a rich archive of studies, making it an essential reference point for those invested in the health and biological sciences.
NEUROCHEMISTRY INTERNATIONAL
Pioneering Discoveries in Neurochemistry and HealthNEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.
CELL PROLIFERATION
Exploring Innovations in Cellular and Molecular BiologyCELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.
JOURNAL OF CELL BIOLOGY
Unveiling Cellular Mysteries, One Study at a TimeJOURNAL OF CELL BIOLOGY, published by Rockefeller University Press, stands as a leading authority in the fields of Cell Biology and Medicine, reflected by its esteemed Q1 ranking in both categories as of 2023. Established in 1955, this journal has become a pivotal platform for disseminating groundbreaking research that enhances our understanding of cellular processes and their implications in various biological contexts. With a broad scope that encompasses experimental and theoretical studies alike, the JOURNAL OF CELL BIOLOGY embraces a rich diversity of topics, making it essential reading for researchers, students, and professionals committed to advancing cellular research. Although the journal does not currently offer open access options, its robust reputation, underscored by a competitive Scopus ranking of 43 out of 285 in the Cell Biology category, ensures that published findings reach a wide audience and influence the ongoing discourse in the life sciences. For those interested in staying at the forefront of cell biological research, the JOURNAL OF CELL BIOLOGY represents a critical resource.
MOLECULAR AND CELLULAR BIOLOGY
Unveiling Cellular Mechanisms for a Brighter TomorrowMOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.
Biology Direct is a leading open-access journal published by BMC, dedicated to disseminating groundbreaking research in the fields of biological sciences. Since its inception in 2006, the journal has emerged as a pivotal platform for scholars, researchers, and practitioners, providing unrestricted access to high-quality, peer-reviewed articles that cover a wide spectrum of topics, including biochemistry, ecology, and applied mathematics. With an impressive ranking in the first quartile across multiple scientific categories, including Agricultural and Biological Sciences and Biochemistry, Genetics, and Molecular Biology, Biology Direct is recognized for its rigorous standards and impactful contributions within the academic community. The journal's open-access model ensures that research findings reach a global audience, fostering collaboration and innovation. Researchers and students looking to stay ahead in the rapidly evolving biological sciences will find Biology Direct an invaluable resource for knowledge and insight.
LIFE SCIENCES
Pioneering research at the forefront of biochemistry and genetics.LIFE SCIENCES, published by PERGAMON-ELSEVIER SCIENCE LTD, is an esteemed international journal that has been advancing the field since its inception in 1962. With an ISSN of 0024-3205 and an E-ISSN of 1879-0631, it serves as a critical forum for researchers, professionals, and students within the realms of biochemistry, genetics, molecular biology, medicine, and pharmacology. Currently ranked in the Q1 category across multiple disciplines, including a remarkable 2nd rank in General Pharmacology, Toxicology, and Pharmaceutics, the journal maintains a prestigious position in academic circles, evidenced by its high impact factor and significant percentile ranks. While LIFE SCIENCES is not an open-access journal, it remains dedicated to publishing high-quality, peer-reviewed research that pushes the boundaries of knowledge and fosters innovation. With converged research interests leading into 2024, LIFE SCIENCES continues to be a pivotal resource for the dissemination of influential findings, making it an indispensable tool for those engaged in the life sciences.
MOLECULAR AND CELLULAR BIOCHEMISTRY
Pioneering Insights in Biochemistry and MedicineMOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.
Genes & Diseases
Pioneering research for a healthier tomorrow.Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.